Skip to content
New: free dose calculator with 14 peptide presets. No signup.
Peptides Academy

SS-31 + MOTS-c + Humanin Mitochondrial Stack

Three mitochondria-targeted peptides addressing different aspects of mitochondrial dysfunction. SS-31 (elamipretide) stabilizes cardiolipin in the inner mitochondrial membrane to restore electron transport chain efficiency. MOTS-c, a mitochondrial-derived peptide, activates AMPK and improves metabolic homeostasis. Humanin, also mitochondria-encoded, protects against apoptosis and oxidative stress. Together, they target mitochondrial structure, energy metabolism, and cell survival.

Quick Comparison

PropertypeptideThe Mitochondrial Stack: SS-31 + MOTS-c + Humanin
SourceSalmon DNA fragmentsVarious sources
Primary MechanismA2A receptor activation, DNA repairVaries by ingredient
Key BenefitsTissue regeneration, anti-inflammation, collagen boostMultiple skin benefits
Best Time to ApplyAM or PMAM or PM
Can Combine?Generally compatible — check specific guidelines.

How to Use Together

Protocols typically run 4–8 weeks. SS-31 is administered subcutaneously at 0.5–5 mg daily — clinical trials in Barth syndrome and heart failure used intravenous dosing, but subcutaneous is the common off-label route. MOTS-c is dosed subcutaneously at 5–10 mg, typically 3–5 times per week. Humanin is administered subcutaneously at low doses (1–5 mg, 3–5 times per week). Some practitioners cycle 4 weeks on, 2 weeks off. Timing is flexible, though morning dosing aligns with circadian metabolic activity patterns.

Safety Notes

SS-31 (elamipretide) has the most human clinical data, having completed Phase 2/3 trials in mitochondrial myopathy and heart failure — it was generally well tolerated, with injection site reactions as the most common adverse event. MOTS-c and humanin are endogenous mitochondrial-derived peptides with favorable safety profiles in animal studies, but human clinical data is extremely limited. Individuals with active cancer should exercise caution, as humanin's anti-apoptotic properties could theoretically interfere with tumor suppression. Consult a qualified medical provider before self-administering.

Recommended Products (3)

Frequently Asked Questions

Why target mitochondria with peptides rather than conventional supplements like CoQ10?
Conventional mitochondrial supplements (CoQ10, NAD+ precursors, PQQ) primarily serve as electron carriers or cofactors. These peptides operate at a more structural and signaling level: SS-31 physically stabilizes cardiolipin, a phospholipid essential for cristae structure and electron transport chain supercomplex assembly. MOTS-c activates AMPK to regulate mitochondrial biogenesis and metabolic switching. Humanin protects against mitochondrial-triggered apoptosis. They address the architecture and regulatory signaling of mitochondria, not just the supply of substrates.
What conditions might benefit from this stack?
Conditions with documented mitochondrial dysfunction include: age-related fatigue and cognitive decline, heart failure (particularly diastolic dysfunction), neurodegenerative diseases (Parkinson's, Alzheimer's), metabolic syndrome and insulin resistance, chronic fatigue syndrome, fibromyalgia, and primary mitochondrial myopathies. The strongest clinical evidence exists for SS-31 in cardiac and mitochondrial myopathy contexts. MOTS-c has metabolic data in exercise and insulin sensitivity. Humanin data is primarily preclinical in neurodegeneration models.
What is MOTS-c and how does it differ from a traditional peptide drug?
MOTS-c is a 16-amino-acid peptide encoded by the mitochondrial genome (within the 12S rRNA gene), not nuclear DNA. It is one of several mitochondrial-derived peptides (MDPs) that function as retrograde signals from mitochondria to the nucleus. MOTS-c activates AMPK, regulates folate-methionine cycling, and improves insulin sensitivity. Its endogenous levels decline with age, and supplementation aims to restore youthful signaling. Unlike synthetic peptide drugs designed to target a receptor, MOTS-c is a replacement of a naturally produced regulatory molecule.
Can I measure mitochondrial function to track this stack's effects?
Direct mitochondrial function testing is limited outside research settings. Accessible proxies include: organic acids testing (which can reveal electron transport chain bottlenecks), lactate-to-pyruvate ratio (elevated in mitochondrial dysfunction), serum coenzyme Q10 levels, and exercise tolerance testing (VO2 max reflects mitochondrial capacity). Subjectively, energy levels, exercise recovery, and cognitive clarity are commonly tracked. The most meaningful assessment combines before-and-after metabolic testing with functional metrics.
Is SS-31 the same as elamipretide?
Yes. SS-31 (also called Bendavia or MTP-131) was renamed elamipretide for clinical development by Stealth BioTherapeutics. It is a synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2) that selectively concentrates in the inner mitochondrial membrane by binding to cardiolipin. It reached Phase 3 clinical trials for Barth syndrome and Phase 2 for primary mitochondrial myopathy and heart failure. The research-grade peptide available outside clinical trials is the same molecule.
Does humanin's anti-apoptotic property present any cancer risk?
This is a legitimate concern. Humanin inhibits Bax-mediated apoptosis, which is a key tumor-suppression pathway. In theory, suppressing apoptosis could allow pre-cancerous cells to survive. Some studies have found elevated humanin in certain tumor types. However, humanin also modulates insulin/IGF-1 signaling and inflammation in ways that may be protective. The net effect on cancer risk is unclear. Individuals with active cancer, a history of cancer, or strong family cancer risk should discuss this with an oncologist before using humanin.
Can I combine this stack with conventional mitochondrial supplements?
Yes, and many practitioners do. CoQ10 (ubiquinol form, 100–200 mg), NAD+ precursors (NMN or NR), PQQ, alpha-lipoic acid, and acetyl-L-carnitine work through different mechanisms than these peptides and are generally considered complementary. CoQ10 supplies electrons at Complex III where SS-31 stabilizes cardiolipin structure; NAD+ precursors feed the electron transport chain while MOTS-c regulates mitochondrial biogenesis. These are synergistic rather than redundant interventions.
How does this stack relate to exercise and metabolic health?
MOTS-c is sometimes called the 'exercise mimetic peptide' because it activates AMPK — the same master metabolic switch triggered by exercise. In mouse studies, MOTS-c improved exercise capacity, glucose uptake, and fat oxidation. SS-31 improved exercise tolerance in heart failure patients in clinical trials. The stack does not replace exercise — rather, it may enhance the mitochondrial adaptations that exercise normally stimulates. For individuals whose mitochondrial dysfunction limits exercise capacity, this stack may help break the cycle of deconditioning.
Are there any interactions between these three peptides?
No direct pharmacological interactions are known. The three peptides act at distinct levels: SS-31 at the inner mitochondrial membrane (structural), MOTS-c at the AMPK/metabolic signaling level, and humanin at the apoptosis/cell survival level. They are mechanistically complementary. The primary practical concern is injection volume and frequency — three separate subcutaneous injections per session can be burdensome. Stability data for combining them in a single syringe is not available; separate administration is the conservative approach.

Other peptide Ingredient Combinations

The Anti-Aging Stack: GHK-Cu + Epitalon

GHK-Cu and Epitalon target two distinct hallmarks of aging — extracellular matrix degradation and te

The Athletic Performance Stack: IGF-1 LR3 + Ipamorelin + BPC-157

The athletic performance stack layers three peptides with distinct but complementary mechanisms to s

The Autoimmune Stack: KPV + BPC-157 + Thymosin Alpha-1 + Low-Dose Naltrexone

A four-component protocol addressing autoimmune dysregulation through complementary immunomodulatory

The Bone Health Stack: BPC-157 + Abaloparatide + Collagen Peptides

A three-component protocol addressing bone mineral density and bone quality. Abaloparatide is a synt

The Cardiac Protection Stack: TB-500 + SS-31 + Humanin

A three-peptide cardiovascular support stack targeting myocardial repair (TB-500), mitochondrial car

The Cognitive Stack: Semax + Selank

The classic Russian nootropic peptide pairing. Semax (an ACTH 4-10 analog) enhances BDNF expression

The Detox Support Stack: BPC-157 + KPV + LL-37 + Larazotide

A four-peptide combination addressing gut barrier integrity, systemic inflammation, and antimicrobia

The Fat Loss Stack: Tesamorelin + CJC-1295/Ipamorelin

Tesamorelin and CJC-1295/Ipamorelin both target the GH axis but through complementary timing and rec

The Fertility Stack: Kisspeptin-10 + Gonadorelin + Oxytocin

A three-peptide protocol targeting the hypothalamic-pituitary-gonadal (HPG) axis at multiple levels.

The GH Stack: CJC-1295 + Ipamorelin

The dual-pathway growth-hormone stack. CJC-1295 (GHRH analog) opens the pituitary somatotroph; Ipamo

The Gut Healing Stack: BPC-157 + KPV + Larazotide

The gut healing stack combines three peptides targeting distinct aspects of intestinal repair: BPC-1

The Hair Restoration Stack: GHK-Cu + Thymosin Beta-4

GHK-Cu and Thymosin Beta-4 (TB-500) target complementary mechanisms in hair follicle biology — coppe

The Healing Stack: BPC-157 + TB-500

The canonical regenerative-peptide pairing. BPC-157 and TB-500 operate through non-overlapping biolo

Immune Support Stack

A combination approach targeting immune function through three complementary mechanisms: adaptive im

The Joint Repair Stack: BPC-157 + Pentosan Polysulfate + TB-500

A comprehensive joint-repair protocol targeting all layers of joint pathology: BPC-157 for periartic

The Longevity Stack: Epitalon + MOTS-c + SS-31

Three peptides targeting different hallmarks of aging: Epitalon for telomerase activation and pineal

The Men's Hormone Stack: CJC-1295/Ipamorelin + Gonadorelin + Kisspeptin-10

A three-peptide protocol designed to optimize the male hormonal axis without exogenous testosterone.

The Metabolic Stack: GLP-1 + GHS

A newer 'metabolic recomposition' pairing some practitioners use: a GLP-1 agonist for appetite and t

The Mood & Anxiety Stack: Selank + NA-Selank-Amidate + DSIP + Oxytocin

A four-peptide anxiolytic and mood-stabilizing protocol. Selank modulates GABA and serotonin signali

The Neuroprotection Stack: Cerebrolysin + Semax + Pinealon

The neuroprotection stack combines three neuropeptide approaches with complementary mechanisms — cer

The Nootropic Stack: Semax + Selank + GH-Axis Support

A three-tier nootropic peptide stack targeting cognitive performance through complementary mechanism

The Post-Surgery Recovery Stack: BPC-157 + TB-500 + Thymosin Alpha-1

The post-surgery recovery stack combines the established BPC-157 + TB-500 tissue-repair pairing with

The Sexual Health Stack: PT-141 + Kisspeptin-10

PT-141 and Kisspeptin-10 target complementary aspects of sexual function — central desire pathways a

The Skin Rejuvenation Stack: GHK-Cu + GH-Axis + Collagen

A multi-level skin rejuvenation protocol combining topical signaling (GHK-Cu), systemic GH-axis elev

The Sleep Stack: DSIP + Ipamorelin

DSIP (Delta Sleep-Inducing Peptide) and ipamorelin target complementary aspects of sleep optimizatio

The Stress Resilience Stack: Selank + DSIP + Semax

A three-peptide stack targeting different dimensions of the stress response: Selank for anxiolysis a

The Tendon Repair Stack: BPC-157 + TB-500 + GHK-Cu

A three-peptide protocol targeting tendon biology specifically. BPC-157 upregulates growth hormone r

The Thymic Regeneration Stack: Thymosin Alpha-1 + Thymalin + Thymulin

Three thymic peptides targeting the age-related involution of the thymus gland. Thymosin alpha-1 enh

The Weight Loss Stack: Semaglutide/Tirzepatide + Tesamorelin

This weight loss stack combines GLP-1 receptor agonist therapy (semaglutide or tirzepatide) with the

The Women's Hormonal Stack: Kisspeptin + BPC-157 + Thymosin Alpha-1

A three-peptide combination addressing women's hormonal health through hypothalamic signaling restor

The Wound Care Stack: BPC-157 + GHK-Cu + TB-500 + Collagen Peptides

A four-component protocol covering the full wound healing cascade. BPC-157 promotes angiogenesis and

Browse All peptide Products

Search

Search across products, blog posts, wiki articles, and more.